Ana Hitri

765 total citations
30 papers, 585 citations indexed

About

Ana Hitri is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Ana Hitri has authored 30 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 8 papers in Psychiatry and Mental health. Recurrent topics in Ana Hitri's work include Neuroscience and Neuropharmacology Research (13 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Schizophrenia research and treatment (7 papers). Ana Hitri is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Schizophrenia research and treatment (7 papers). Ana Hitri collaborates with scholars based in United States, Australia and Sweden. Ana Hitri's co-authors include Stephen I. Deutsch, Richard Jed Wyatt, John Mastropaolo, Joel E. Kleinman, Bruce I. Diamond, Yasmin L. Hurd, Mark B. Hamner, Richard L. Borison, Manuel F. Casanova and Harold L. Klawans and has published in prestigious journals such as American Journal of Psychiatry, Annals of Neurology and Biological Psychiatry.

In The Last Decade

Ana Hitri

30 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Hitri United States 16 386 203 129 79 79 30 585
Jantiena B. Sebens Netherlands 15 381 1.0× 216 1.1× 83 0.6× 64 0.8× 63 0.8× 24 540
Hiroshi Mitsushio Japan 12 467 1.2× 284 1.4× 125 1.0× 50 0.6× 87 1.1× 22 709
S Caldecott-Hazard United States 14 450 1.2× 178 0.9× 165 1.3× 61 0.8× 133 1.7× 19 670
Kevin P. Nanry United States 12 428 1.1× 162 0.8× 86 0.7× 131 1.7× 140 1.8× 23 603
Manuelle Touzard France 11 452 1.2× 320 1.6× 107 0.8× 67 0.8× 49 0.6× 14 637
Bruce I. Diamond United States 14 306 0.8× 141 0.7× 221 1.7× 73 0.9× 100 1.3× 27 721
Simona Prisco Italy 8 425 1.1× 232 1.1× 79 0.6× 72 0.9× 86 1.1× 8 536
Jason Katner United States 11 290 0.8× 154 0.8× 123 1.0× 38 0.5× 131 1.7× 14 484
Peter Dufeu Germany 9 401 1.0× 164 0.8× 90 0.7× 65 0.8× 97 1.2× 11 579
Gerard D. Pratt United Kingdom 12 415 1.1× 237 1.2× 85 0.7× 51 0.6× 55 0.7× 13 608

Countries citing papers authored by Ana Hitri

Since Specialization
Citations

This map shows the geographic impact of Ana Hitri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Hitri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Hitri more than expected).

Fields of papers citing papers by Ana Hitri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Hitri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Hitri. The network helps show where Ana Hitri may publish in the future.

Co-authorship network of co-authors of Ana Hitri

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Hitri. A scholar is included among the top collaborators of Ana Hitri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Hitri. Ana Hitri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hitri, Ana. (1996). Effect of Cocaine on Dopamine Transporter Receptors Depends on Routes of Chronic Cocaine Administration. Neuropsychopharmacology. 14(3). 205–210. 24 indexed citations
2.
Taira, Tomi, Ana Hitri, Stephen I. Deutsch, et al.. (1995). Alterations in brain monoamines and GABAA receptors in transgenic mice overexpressing TGFα. Pharmacology Biochemistry and Behavior. 50(4). 593–600. 13 indexed citations
3.
Hitri, Ana, Manuel F. Casanova, Joel E. Kleinman, Daniel R. Weinberger, & R J Wyatt. (1995). Age-related changes in [3H]GBR 12935 binding site density in the prefrontal cortex of controls and schizophrenics. Biological Psychiatry. 37(3). 175–182. 25 indexed citations
4.
Deutsch, Stephen I., CHAN H. PARK, & Ana Hitri. (1994). Allosteric effects of a GABA receptor-active steroid are altered by stress. Pharmacology Biochemistry and Behavior. 47(4). 913–917. 14 indexed citations
5.
Hitri, Ana, Yasmin L. Hurd, Richard Jed Wyatt, & Stephen I. Deutsch. (1994). Molecular, Functional and Biochemical Characteristics of the Dopamine Transporter. Clinical Neuropharmacology. 17(1). 1–22. 70 indexed citations
6.
Chrapusta, Stanisław J., et al.. (1994). Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. British Journal of Pharmacology. 113(4). 1391–1399. 43 indexed citations
7.
Hitri, Ana, et al.. (1994). Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. American Journal of Psychiatry. 151(7). 1074–1076. 42 indexed citations
8.
Deutsch, Stephen I. & Ana Hitri. (1993). Measurement of an Explosive Behavior in the Mouse, Induced by MK-801, a PCP Analogue. Clinical Neuropharmacology. 16(3). 251–257. 26 indexed citations
9.
Hitri, Ana, et al.. (1993). Differentiation Between MK-801− and Apomorphine-Induced Stereotyped Behaviors in Mice. Clinical Neuropharmacology. 16(3). 220–236. 15 indexed citations
10.
PARK, CHAN H., et al.. (1993). Swim stress selectively alters the specific binding of a benzodiazepine antagonist in mice. Pharmacology Biochemistry and Behavior. 45(2). 299–304. 15 indexed citations
11.
Hitri, Ana & Richard Jed Wyatt. (1993). Regional Differences in Rat Brain Dopamine Transporter Binding. Clinical Neuropharmacology. 16(6). 525–539. 16 indexed citations
12.
Hitri, Ana, et al.. (1991). Characteristics of [3H]GBR 12935 Binding in the Human and Rat Frontal Cortex. Journal of Neurochemistry. 56(5). 1663–1672. 26 indexed citations
13.
Sethi, Kapil D., Ana Hitri, & Bruce I. Diamond. (1990). Phenytoin potentiation of neuroleptic‐induced dyskinesias. Movement Disorders. 5(4). 325–327. 9 indexed citations
14.
Hitri, Ana, Hung Q. Nguyen, & Bruce I. Diamond. (1989). The role of the medial prefrontal cortex in yawning behavior. Biological Psychiatry. 25(7). A48–A49. 1 indexed citations
15.
Carvey, Paul M., Ana Hitri, Christopher G. Goetz, Caroline M. Tanner, & Harold L. Klawans. (1988). Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sciences. 42(22). 2207–2215. 16 indexed citations
16.
Hitri, Ana, et al.. (1987). Drug Levels and Antiparkinsonian Drugs in Neuroleptic-Treated Schizophrenic Patients. Clinical Neuropharmacology. 10(3). 261–271. 4 indexed citations
17.
Hitri, Ana, et al.. (1987). Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.. PubMed. 23(1). 33–7. 14 indexed citations
18.
Hitri, Ana, et al.. (1985). Neuroleptic blood levels and tardive dyskinesia.. PubMed. 40. 29–32. 1 indexed citations
19.
Hitri, Ana, William J. Weiner, Richard L. Borison, et al.. (1978). Dopamine binding following prolonged haloperidol pretreament. Annals of Neurology. 3(2). 134–140. 40 indexed citations
20.
Ungar, Frieda, Ana Hitri, & Spyridon G.A. Alivisatos. (1976). Drug antagonism and reversibility of the binding of indoleamines in brain. European Journal of Pharmacology. 36(1). 115–125. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026